Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CLB Plesmanlaan T-cell activation ELISA:

This article was originally published in Clinica

Executive Summary

CLB Plesmanlaan has launched a T-cell activation test based on soluble CD 27. Soluble CD27 increases in patients suffering from immunopathological diseases, suggesting its use in vivo as a marker for T-cell activation. Sensitivity of the new ELISA test is 1 unit per ml, and intra- and interassay variations are less than 10%, the manufacturer claims. All necessary components are included, and the kit contains sufficient reagents for 288 tests. The assay can be performed in about four hours after overnight coating.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093702

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel